1. Home
  2. VCEL vs BKD Comparison

VCEL vs BKD Comparison

Compare VCEL & BKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • BKD
  • Stock Information
  • Founded
  • VCEL 1989
  • BKD 2005
  • Country
  • VCEL United States
  • BKD United States
  • Employees
  • VCEL N/A
  • BKD N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • BKD Hospital/Nursing Management
  • Sector
  • VCEL Health Care
  • BKD Health Care
  • Exchange
  • VCEL Nasdaq
  • BKD Nasdaq
  • Market Cap
  • VCEL 2.1B
  • BKD 1.7B
  • IPO Year
  • VCEL 1997
  • BKD 2005
  • Fundamental
  • Price
  • VCEL $31.42
  • BKD $7.48
  • Analyst Decision
  • VCEL Strong Buy
  • BKD Buy
  • Analyst Count
  • VCEL 6
  • BKD 5
  • Target Price
  • VCEL $61.50
  • BKD $7.80
  • AVG Volume (30 Days)
  • VCEL 677.8K
  • BKD 2.7M
  • Earning Date
  • VCEL 11-06-2025
  • BKD 11-05-2025
  • Dividend Yield
  • VCEL N/A
  • BKD N/A
  • EPS Growth
  • VCEL 2045.40
  • BKD N/A
  • EPS
  • VCEL 0.13
  • BKD N/A
  • Revenue
  • VCEL $249,119,000.00
  • BKD $3,051,698,000.00
  • Revenue This Year
  • VCEL $18.35
  • BKD $8.33
  • Revenue Next Year
  • VCEL $22.47
  • BKD N/A
  • P/E Ratio
  • VCEL $234.59
  • BKD N/A
  • Revenue Growth
  • VCEL 16.13
  • BKD 4.23
  • 52 Week Low
  • VCEL $30.26
  • BKD $4.45
  • 52 Week High
  • VCEL $63.00
  • BKD $8.29
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 36.46
  • BKD 47.07
  • Support Level
  • VCEL $30.26
  • BKD $7.34
  • Resistance Level
  • VCEL $33.92
  • BKD $8.29
  • Average True Range (ATR)
  • VCEL 1.52
  • BKD 0.21
  • MACD
  • VCEL -0.22
  • BKD -0.03
  • Stochastic Oscillator
  • VCEL 17.55
  • BKD 14.74

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About BKD Brookdale Senior Living Inc.

Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.

Share on Social Networks: